🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Albemarle Corporation ALB SPX

Basic Materials · Specialty Chemicals · United States
https://www.albemarle.com
Company Profile ↓
$124.74
+75.91% 1Y
Mkt Cap$14.71B
P/E-35.64
P/B1.99
Div. Yield1.29%
52W High$215.07
52W Low$66.40
Book Value$64.60
EPS (TTM)$-3.50

Company Overview

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Why Investors Should Care

Healthy Margins

Operating margin of 24.8% supports profitability.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.20.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $5.14B (-4.4% YoY); net profit $-510.63M.
  • Trailing 12 Months Year-on-year growth — revenue +32.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR -11.1%, profit CAGR -39.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-11.10%
1 Year:32.70%

Compounded Profit Growth

5 Years:-39.66%
1 Year:-

Stock Price Performance

1 Year:+75.91%
6 Months:-25.96%
3 Months:-34.13%
1 Month:-26.80%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 39% of range
$66.40 $215.07
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)29.68 · Oversold
Price Performance
1M-26.80%
3M-34.13%
6M-25.96%
1Y+75.91%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -11.1% CAGR over 5 years.
  • Earnings shrank at -39.7% CAGR over 5 years.
  • Trading 42.0% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-35.64
Industry PE
23.08
Forward P/E
9.59
PEG Ratio
0.79
Book Value
$64.60
Price to Book
1.99
P/S
2.76
EV/EBITDA
17.09
Dividend Yield
1.29%

Growth (CAGR)

Revenue 5Y
-11.10%
Profit 5Y
-39.66%
Revenue (YoY)
32.70%
Earnings (YoY)
-

Profitability & Returns

ROCE
-2.36%
ROE
-1.82%
ROA
1.60%
Profit Margin
-4.24%
Op Margin
24.79%
Gross Margin
18.53%
EPS (Latest Qtr)
$2.34
EPS (TTM)
$-3.50

Balance Sheet & Liquidity

Debt/Equity
0.20
Quick Ratio
1.11
Current Ratio
2.07
Debt
$2.01B
Total Assets
$15.14B
Current Assets
$3.26B
Working Capital
$2.21B

Ownership

Promoter Holding
0.19%
Chg in Prom Hold
0.00%
FII / Inst Holding
96.34%
Chg in FII Hold
0.09%

Financial Snapshot

Enterprise Value
$14.71B
Total Revenue (TTM)
$5.49B
EBITDA
$1.07B
Free Cash Flow
$716.71M
Operating Cash Flow
$1.08B
Shares Outstanding
117.93M
Gross Margin
18.53%
Payout Ratio
57.97%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ALB Albemarle Corporation SPX 124.74 -35.64 $14.71B 1.29% -2.36% -1.82% -11.10% -39.66%
2 LIN Linde plc NDXSPX 514.15 34.05 $237.72B 1.22% 12.46% 18.23% 13.90% 18.47%
3 NEM Newmont Corporation SPX 95.21 12.35 $101.64B 1.10% - 25.83% 6.53% 20.15%
4 FCX Freeport-McMoRan Inc. SPX 60.97 32.26 $87.65B 0.97% 12.50% 15.63% 1.35% -1.26%
5 SHW The Sherwin-Williams Company SPX 332.29 31.92 $81.95B 0.97% 21.93% 60.72% 6.18% 8.26%
6 ECL Ecolab Inc. SPX 270.25 36.57 $76.06B 1.07% 14.29% 22.43% 6.17% 9.18%
7 CRH CRH plc SPX 103.96 19.04 $69.47B 1.52% 10.97% 15.81% 6.41% 9.30%
8 APD Air Products and Chemicals, Inc. SPX 293.69 30.98 $65.40B 2.40% -0.62% 12.35% -1.77% -39.16%
9 CTVA Corteva, Inc. SPX 84.45 46.15 $56.48B 0.84% - 5.14% 2.86% 9.94%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --------722.06M737.26M754.87M857.79M821.63M853.87M777.75M921.70M832.06M885.05M879.75M992.56M738.85M764.05M746.87M829.29M773.90M830.57M1.13B1.48B2.09B2.58B2.37B2.31B1.36B1.43B1.35B1.08B1.33B1.31B1.43B1.43B
Cost of Revenue -----------------------------------920.58M1.13B1.19B1.23B927.76M
Gross Profit 191.38M212.03M219.04M237.77M242.53M248.10M238.97M240.97M254.96M271.96M275.66M303.70M304.98M311.36M280.54M320.38M283.49M325.91M309.87M338.51M242.02M233.36M254.06M263.69M248.42M249.27M449.03M580.42M1.04B1.28B558.49M54.93M38.94M-10.58M-104.03M156.30M196.88M117.61M197.93M500.97M
Operating Expenses -----------------------------------137.60M144.90M151.25M167.68M146.58M
Operating Income 36.69M79.26M86.42M-242.80M123.49M124.91M-121.70M138.04M147.42M-182.62M390.35M163.76M-155.15M185.74M186.15M-124.04M112.20M144.43M155.86M542.33M131.52M311.98M434.10M890.98M1.10B140.00M-140.01M-179.51M-492.61M-1.11B18.70M51.98M-33.64M30.25M354.39M
EBITDA -----------------------------------191.76M209.70M-23.70M-63.50M445.12M
Interest Expense -----------------------------------48.98M49.94M50.96M57.78M33.12M
Pretax Income ------------------------------------18.97M-8.97M-239.15M-284.99M254.19M
Tax Provision ------------------------------------3.98M34.09M-30.57M157.33M21.51M
Net Income 43.12M52.15M65.39M174.25M228.19M-314.82M128.22M602.09M51.21M103.33M118.67M-218.37M131.76M302.46M129.75M129.60M133.57M154.20M155.07M90.39M107.20M85.62M98.30M95.68M424.60M-392.78M253.38M406.77M897.22M1.24B650.04M302.53M2.45M-188.20M-1.07B41.35M22.90M-160.69M-414.18M319.09M
Diluted EPS 0.400.460.581.552.02-2.781.135.300.450.921.06-1.182.731.20-1.261.451.46-1.010.800.920.843.62-3.362.153.467.6110.515.522.57-0.08-1.96-9.450.00-0.16-1.72-3.872.34
R&D Expense 26.49M21.93M21.90M-19.87M20.50M21.01M-24.32M17.34M21.76M-20.99M16.07M16.61M-14.98M13.46M15.59M-16.10M14.21M13.53M14.64M13.98M13.29M16.08M17.39M18.36M20.47M21.42M21.08M23.53M20.77M22.40M14.10M12.44M12.67M-9.17M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 2.47B2.01B2.36B2.87B2.52B2.39B2.45B2.83B2.68B3.07B3.37B3.59B3.13B3.33B7.32B9.62B5.38B5.14B
Cost of Revenue --------------4.25B8.43B5.31B4.47B
Gross Profit 607.67M483.86M741.91M954.95M898.84M850.47M770.85M860.23M970.31M1.11B1.22B1.26B994.85M997.97M3.07B1.19B62.54M668.72M
Operating Expenses --------------596.13M995.73M704.77M601.43M
Operating Income 220.92M186.28M401.94M517.79M399.78M576.67M271.30M345.11M600.98M571.66M911.54M666.12M505.81M798.43M2.48B190.18M-642.23M67.28M
EBITDA --------------2.86B792.75M-1.01B314.26M
Interest Expense --------------122.97M116.07M165.62M207.65M
Pretax Income --------------2.43B246.74M-1.76B-552.07M
Tax Provision --------------390.59M430.28M87.08M156.88M
Net Income 194.20M178.37M315.78M392.11M311.54M413.17M133.32M334.91M643.67M54.85M693.56M533.23M375.76M123.67M2.69B1.57B-1.18B-510.63M
Diluted EPS 2.091.943.434.283.474.901.693.005.680.496.345.023.521.0622.8413.36-11.20-5.76
R&D Expense 67.29M60.92M58.39M77.08M78.92M82.25M88.31M89.19M80.47M84.33M70.05M58.29M59.21M54.03M71.98M85.72M86.72M51.40M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --2.77B3.07B3.20B3.44B3.58B5.20B9.60B8.16B7.75B7.58B9.86B10.45B-15.46B18.27B16.61B16.37B
Current Assets ---------------5.19B5.22B3.84B4.01B
Cash & Equivalents 130.55M253.30M308.79M529.65M469.42M477.70M477.24M2.49B213.73M2.27B1.14B555.32M613.11M--1.50B889.90M1.19B1.62B
Inventory ---------------2.08B2.16B1.50B1.18B
Receivables ---------------1.19B1.21B742.20M593.50M
Total Liabilities ---------------7.27B8.61B6.41B6.59B
Current Liabilities --353.26M364.18M401.18M385.01M436.36M1.14B1.62B1.14B1.20B1.18B1.41B1.80B-2.74B3.56B1.97B1.80B
Long Term Debt --776.40M851.93M749.26M686.59M1.05B2.22B3.14B2.12B1.42B1.40B2.86B2.77B-3.21B3.54B3.12B3.12B
Total Debt ---------------3.32B4.28B3.62B3.30B
Total Equity 1.33B1.12B1.21B1.42B1.59B1.83B1.63B1.36B3.25B3.80B3.67B3.59B3.93B4.27B-7.98B9.41B9.96B9.53B
Shares Outstanding ---------------117.17M117.36M117.56M117.72M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 327.16M358.52M331.31M487.36M488.77M432.86M492.61M360.81M735.52M303.98M546.16M719.37M798.91M-1.91B1.33B687.88M1.28B
Investing Cash Flow -163.70M-121.63M-92.19M-212.94M-301.16M-157.74M-46.13M-2.16B2.92B-357.80M-303.69M-1.66B-863.57M--1.42B-2.56B-1.58B-146.01M
Financing Cash Flow -25.03M-180.78M-7.94M-329.12M-177.29M-288.05M1.61B-478.45M-1.58B-1.09B-786.53M1.04B177.26M-611.89M623.91M1.24B-834.19M
Capital Expenditure -99.74M-100.79M-75.48M-190.57M-280.87M-155.35M-110.58M-227.65M-196.65M-317.70M-699.99M-851.80M-850.48M--1.26B-2.15B-1.68B-589.80M
Free Cash Flow 227.42M257.74M255.83M296.79M207.89M277.51M382.03M133.16M538.87M-13.72M-153.83M-132.42M-51.56M-646.20M-827.96M-992.65M692.47M
Net Change in Cash --------------1.10B-614.08M344.84M302.07M
Share Buybacks 168.95M5.81M14.95M178.13M63.58M582.30M150.00M00250.00M500.00M00-----
Dividends Paid ----000-----------

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 24.6%24.1%31.4%33.3%35.7%35.5%31.5%30.4%36.2%36.0%36.1%35.0%31.8%30.0%42.0%12.3%1.2%13.0%
Operating Margin % 9.0%9.3%17.0%18.0%15.9%24.1%11.1%12.2%22.4%18.6%27.0%18.6%16.2%24.0%33.9%2.0%-11.9%1.3%
Net Margin % 7.9%8.9%13.4%13.7%12.4%17.3%5.5%11.8%24.0%1.8%20.6%14.9%12.0%3.7%36.7%16.4%-21.9%-9.9%
ROE % 17.4%14.8%22.3%24.6%17.0%25.4%9.8%10.3%17.0%1.5%19.3%13.6%8.8%-33.7%16.7%-11.8%-5.4%
ROCE % -7.7%14.9%18.5%13.1%18.3%6.7%4.3%8.6%8.7%14.2%7.9%5.8%-19.5%1.3%-4.4%0.5%

Shareholding Pattern

Insiders
0.19%
Institutions
96.34%
Public Float
96.52%

Top Institutional Holders

#Holder% HeldSharesValue
1 Capital World Investors 8.34% 9.84M $1.27B
2 Blackrock Inc. 7.41% 8.73M $1.12B
3 Vanguard Capital Management LLC 6.50% 7.66M $986.51M
4 Vanguard Portfolio Management LLC 5.35% 6.32M $813.10M
5 State Street Corporation 4.43% 5.22M $672.64M
6 Geode Capital Management, LLC 2.91% 3.43M $442.13M
7 Bank of America Corporation 2.52% 2.98M $383.20M
8 Primecap Management Company 2.26% 2.66M $343.08M
9 Two Sigma Investments, LP 1.97% 2.32M $298.81M
10 Morgan Stanley 1.91% 2.25M $289.42M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ALB

Yahoo Finance Wed, 15 Jul 2026

Top Stock Picks for Week of July 13, 2026

An Infrastructure Services Company with Financial Flexibility to Invest and Return Capital and a Specialty Chemicals Company That's a Potential Top Growth Pick

Yahoo Finance Wed, 15 Jul 2026

Valmont's Shares Jump 65% in a Year: What's Behind the Surge?

VMI shares surge 64.6% in a year as utility demand, manufacturing gains and restructuring expanded margins and fueled a strong backlog.

Yahoo Finance Wed, 15 Jul 2026

Here's Why You Should Retain Nutrien Stock in Your Portfolio

NTR is riding healthy fertilizer demand, record potash sales and cost cuts, but higher input costs challenge margin gains.

Yahoo Finance Wed, 15 Jul 2026

Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know

Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Yahoo Finance ue, 14 Jul 2026

Albemarle Stock Loses 25% in a Month: What Should Investors Do Now?

Albemarle's 25% slide reflects weaker lithium prices, but a healthy demand outlook, productivity gains and rising earnings estimates may change the picture.

Yahoo Finance ue, 14 Jul 2026

Zacks.com featured highlights Ternium, Everus, TAT and Sunstone Hotel

Ternium, Everus, TAT and Sunstone Hotel have been highlighted in this Screen of The Week article.

ALB — Frequently Asked Questions

What is the current share price of Albemarle Corporation (ALB)?

As of 2026-07-15 16:51 PDT, Albemarle Corporation (ALB) trades at $124.74 on NYSE. Its 52-week range is $66.40 to $215.07.

What is the market capitalisation of ALB?

Albemarle Corporation (ALB) has a market capitalisation of $14.71B on NYSE.

What is the P/E ratio of ALB?

ALB trades at a trailing price-to-earnings (P/E) ratio of -35.64. The industry average P/E is 23.08. Its price-to-book (P/B) ratio is 1.99.

Does ALB pay a dividend?

Albemarle Corporation (ALB) currently offers a dividend yield of 1.29%.

What is the return on equity (ROE) of ALB?

ALB has a return on equity (ROE) of -1.82%. Its return on capital employed (ROCE) is -2.36%.

Is ALB a good stock to buy?

This page provides a data-driven analysis of Albemarle Corporation (ALB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space